Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Not yet recruiting × GastroEsophageal Cancer × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 29 Leukemia, Myeloid, Acute 27 Neoplasms 24 Recurrence 22 Multiple Myeloma 22 Colorectal Neoplasms 20 Neoplasm Metastasis 18 Breast Neoplasms 18 Lymphoma, B-Cell 17 Advanced Solid Tumors 16 Squamous Cell Carcinoma of Head and Neck 13 Melanoma 13 Lung Neoplasms 13 Hematologic Neoplasms 12 Glioblastoma 12 Pancreatic Neoplasms 11 Glioma 11 Lymphoma, Non-Hodgkin 10 Carcinoma, Hepatocellular 10 Advanced Solid Tumor 10 Small Cell Lung Carcinoma 9 Prostatic Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Ovarian Neoplasms 9 Lymphoma 9 Leukemia 9 Brain Neoplasms 9 Sarcoma 8 Head and Neck Neoplasms 8 Esophageal Neoplasms 8

Interventions

bemarituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06978062 2025-06-05

NeoBEMA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Not yet recruiting

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡